IHC Matters: Incorporating IHC analysis to H&E Whole Slide Image Analysis for Improved Cancer Grading via Two-stage Multimodal Bilinear Pooling Fusion

Read original: arXiv:2405.08197 - Published 5/15/2024 by Jun Wang, Yu Mao, Yufei Cui, Nan Guan, Chun Jason Xue
Total Score

0

IHC Matters: Incorporating IHC analysis to H&E Whole Slide Image Analysis for Improved Cancer Grading via Two-stage Multimodal Bilinear Pooling Fusion

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper presents a two-stage multimodal bilinear pooling fusion approach to improve cancer grading by incorporating immunohistochemistry (IHC) analysis into the analysis of hematoxylin and eosin (H&E) whole slide images.
  • The proposed method aims to leverage the complementary information from both modalities to enhance the performance of cancer grading tasks.
  • The authors conduct experiments on a dataset of breast cancer samples and demonstrate the advantages of their approach compared to unimodal baselines.

Plain English Explanation

Cancer diagnosis and grading are critical for determining the appropriate treatment plan for patients. Traditionally, pathologists have relied on analyzing H&E-stained whole slide images to assess the characteristics of tumor cells and tissues. However, additional information from IHC staining, which can reveal the expression of specific proteins, can provide valuable insights that may not be captured by H&E analysis alone.

The researchers in this study developed a novel method to combine the information from H&E and IHC images to improve the accuracy of cancer grading. Their approach involves a two-stage process:

  1. First, they use deep learning models to extract relevant features from both the H&E and IHC images separately.
  2. Then, they fuse these features using a "bilinear pooling" technique, which allows the model to capture the interactions and correlations between the different modalities.

By incorporating the complementary information from IHC analysis, the researchers were able to achieve better performance in cancer grading compared to using H&E images alone. This suggests that integrating multiple modalities can lead to more comprehensive and accurate cancer diagnosis and staging, which is crucial for guiding treatment decisions and improving patient outcomes.

Technical Explanation

The authors of this paper propose a two-stage multimodal bilinear pooling fusion approach to incorporate IHC analysis into the analysis of H&E whole slide images for improved cancer grading. In the first stage, they use separate deep learning models to extract features from the H&E and IHC images. For the H&E images, they employ a modified version of the Weakly-supervised Learning for Improved Breast Cancer Diagnosis via DeepLearning-based Prediction of Breast Cancer Tumor Cellularity architecture. For the IHC images, they use a network based on the Using Multi-scale Swin Transformer and HTC Data Augmentation for Improved Breast Cancer Histology Classification model.

In the second stage, the authors fuse the features from the H&E and IHC modalities using a bilinear pooling technique. This allows the model to capture the interactions and correlations between the two modalities, which can provide a more comprehensive representation for the cancer grading task. The authors compare their proposed approach to unimodal baselines and demonstrate its superior performance on a breast cancer dataset.

Critical Analysis

The authors acknowledge several limitations in their study. First, the dataset used is relatively small, which may limit the generalizability of their findings. Additionally, the proposed approach relies on having access to both H&E and IHC images, which may not always be available in clinical practice. Further research is needed to explore the feasibility and effectiveness of their method in real-world settings.

Another potential concern is the interpretability of the bilinear pooling fusion approach. While the authors show improved performance, the underlying mechanisms by which the multimodal information is combined and leveraged may not be fully transparent. Exploring explainable AI techniques could help provide better insights into the decision-making process of the model.

Additionally, the authors do not discuss the potential ethical implications of their work, such as issues related to data bias, privacy, and fairness in the context of medical AI applications. These aspects should be carefully considered as the research progresses.

Conclusion

This paper presents a promising approach for incorporating IHC analysis into the analysis of H&E whole slide images to improve cancer grading. By leveraging the complementary information from these two modalities, the researchers were able to achieve enhanced performance compared to using H&E images alone. This suggests that multimodal approaches can be valuable for enhancing the accuracy and comprehensiveness of cancer diagnosis and staging, which is crucial for informing treatment decisions and improving patient outcomes.

However, the authors acknowledge several limitations, and further research is needed to address issues related to dataset size, real-world applicability, model interpretability, and ethical considerations. As the field of weakly supervised learning for PD-L1 classification in medical imaging continues to evolve, it will be important to carefully consider these aspects to ensure the responsible development and deployment of such AI-powered tools in clinical practice.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

IHC Matters: Incorporating IHC analysis to H&E Whole Slide Image Analysis for Improved Cancer Grading via Two-stage Multimodal Bilinear Pooling Fusion
Total Score

0

IHC Matters: Incorporating IHC analysis to H&E Whole Slide Image Analysis for Improved Cancer Grading via Two-stage Multimodal Bilinear Pooling Fusion

Jun Wang, Yu Mao, Yufei Cui, Nan Guan, Chun Jason Xue

Immunohistochemistry (IHC) plays a crucial role in pathology as it detects the over-expression of protein in tissue samples. However, there are still fewer machine learning model studies on IHC's impact on accurate cancer grading. We discovered that IHC and H&E possess distinct advantages and disadvantages while possessing certain complementary qualities. Building on this observation, we developed a two-stage multi-modal bilinear model with a feature pooling module. This model aims to maximize the potential of both IHC and HE's feature representation, resulting in improved performance compared to their individual use. Our experiments demonstrate that incorporating IHC data into machine learning models, alongside H&E stained images, leads to superior predictive results for cancer grading. The proposed framework achieves an impressive ACC higher of 0.953 on the public dataset BCI.

Read more

5/15/2024

Advancing H&E-to-IHC Stain Translation in Breast Cancer: A Multi-Magnification and Attention-Based Approach
Total Score

0

Advancing H&E-to-IHC Stain Translation in Breast Cancer: A Multi-Magnification and Attention-Based Approach

Linhao Qu, Chengsheng Zhang, Guihui Li, Haiyong Zheng, Chen Peng, Wei He

Breast cancer presents a significant healthcare challenge globally, demanding precise diagnostics and effective treatment strategies, where histopathological examination of Hematoxylin and Eosin (H&E) stained tissue sections plays a central role. Despite its importance, evaluating specific biomarkers like Human Epidermal Growth Factor Receptor 2 (HER2) for personalized treatment remains constrained by the resource-intensive nature of Immunohistochemistry (IHC). Recent strides in deep learning, particularly in image-to-image translation, offer promise in synthesizing IHC-HER2 slides from H&E stained slides. However, existing methodologies encounter challenges, including managing multiple magnifications in pathology images and insufficient focus on crucial information during translation. To address these issues, we propose a novel model integrating attention mechanisms and multi-magnification information processing. Our model employs a multi-magnification processing strategy to extract and utilize information from various magnifications within pathology images, facilitating robust image translation. Additionally, an attention module within the generative network prioritizes critical information for image distribution translation while minimizing less pertinent details. Rigorous testing on a publicly available breast cancer dataset demonstrates superior performance compared to existing methods, establishing our model as a state-of-the-art solution in advancing pathology image translation from H&E to IHC staining.

Read more

8/6/2024

🤷

Total Score

0

Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer

Biagio Brattoli, Mohammad Mostafavi, Taebum Lee, Wonkyung Jung, Jeongun Ryu, Seonwook Park, Jongchan Park, Sergio Pereira, Seunghwan Shin, Sangjoon Choi, Hyojin Kim, Donggeun Yoo, Siraj M. Ali, Kyunghyun Paeng, Chan-Young Ock, Soo Ick Cho, Seokhwi Kim

Despite advancements in methodologies, immunohistochemistry (IHC) remains the most utilized ancillary test for histopathologic and companion diagnostics in targeted therapies. However, objective IHC assessment poses challenges. Artificial intelligence (AI) has emerged as a potential solution, yet its development requires extensive training for each cancer and IHC type, limiting versatility. We developed a Universal IHC (UIHC) analyzer, an AI model for interpreting IHC images regardless of tumor or IHC types, using training datasets from various cancers stained for PD-L1 and/or HER2. This multi-cohort trained model outperforms conventional single-cohort models in interpreting unseen IHCs (Kappa score 0.578 vs. up to 0.509) and consistently shows superior performance across different positive staining cutoff values. Qualitative analysis reveals that UIHC effectively clusters patches based on expression levels. The UIHC model also quantitatively assesses c-MET expression with MET mutations, representing a significant advancement in AI application in the era of personalized medicine and accumulating novel biomarkers.

Read more

7/31/2024

🤿

Total Score

0

New!Deep learning-based classification of breast cancer molecular subtypes from H&E whole-slide images

Masoud Tafavvoghi, Anders Sildnes, Mehrdad Rakaee, Nikita Shvetsov, Lars Ailo Bongo, Lill-Tove Rasmussen Busund, Kajsa M{o}llersen

Classifying breast cancer molecular subtypes is crucial for tailoring treatment strategies. While immunohistochemistry (IHC) and gene expression profiling are standard methods for molecular subtyping, IHC can be subjective, and gene profiling is costly and not widely accessible in many regions. Previous approaches have highlighted the potential application of deep learning models on H&E-stained whole slide images (WSI) for molecular subtyping, but these efforts vary in their methods, datasets, and reported performance. In this work, we investigated whether H&E-stained WSIs could be solely leveraged to predict breast cancer molecular subtypes (luminal A, B, HER2-enriched, and Basal). We used 1,433 WSIs of breast cancer in a two-step pipeline: first, classifying tumor and non-tumor tiles to use only the tumor regions for molecular subtyping; and second, employing a One-vs-Rest (OvR) strategy to train four binary OvR classifiers and aggregating their results using an eXtreme Gradient Boosting (XGBoost) model. The pipeline was tested on 221 hold-out WSIs, achieving an overall macro F1 score of 0.95 for tumor detection and 0.73 for molecular subtyping. Our findings suggest that, with further validation, supervised deep learning models could serve as supportive tools for molecular subtyping in breast cancer. Our codes are made available to facilitate ongoing research and development.

Read more

9/17/2024